Microneedling for Melasma & Pigmentation — The Honest Caveats

The honest framing

What melasma actually is

Melasma is acquired hyperpigmentation of sun-exposed skin, most often on the face. It is driven by a combination of hormonal (estrogen and progesterone), genetic, and UV factors. Pigment can sit in the epidermis (responsive to treatment), the dermis (less responsive), or both.

Two features make melasma difficult: (1) it tends to recur whenever the triggers (sun, hormones, heat) return; (2) any inflammation in the skin can trigger melanocytes to upregulate pigment production — the exact opposite of what we want.

Why microneedling is risky for melasma

Microneedling triggers a wound-healing inflammation. In skin without melasma tendency, this is benign — new collagen, no pigment problem. In melasma-prone skin, the inflammatory cascade can drive melanocyte hyperactivity, producing post-inflammatory hyperpigmentation (PIH) that worsens or expands the existing melasma.

The risk is most acute at:

• Deeper needle depths (above 1.5 mm)
• Fitzpatrick IV, V, VI skin
• Active melasma (rather than dormant)
• Without adequate pre- and post-treatment topical regimens
• Without strict sun protection

When microneedling for pigmentation can be acceptable

There are protocols that use very shallow microneedling (0.5–0.8 mm) as a vehicle to deliver topicals (tranexamic acid, vitamin C, growth factors) into the upper dermis. At this depth the inflammatory response is minimal and the topical delivery effect dominates. This can produce gradual lightening of epidermal melasma when combined with strict topical management and sun avoidance.

Generally acceptable scenarios:

• Fitzpatrick I–III skin with mild to moderate epidermal melasma, after baseline topical control
• Shallow protocols (0.5–0.8 mm) combined with topical delivery
• As maintenance after melasma is already controlled by topicals/laser

Generally not recommended:

• Active flaring melasma in any skin type
• Fitzpatrick V–VI with deep needling for any indication if melasma is present
• Recent sun exposure (within 4 weeks)
• Patients on hormonal triggers without addressing those first

What we use instead for melasma

First-line management for melasma is layered and patient:

• Strict sun protection — broad-spectrum SPF 50+ daily, physical barriers (hats, sunglasses), iron-oxide-containing sunscreens that block visible light (relevant for melasma, which responds to visible light not just UV).
• Topical regimens — hydroquinone (alone or in triple-combination Kligman’s formula with tretinoin and a corticosteroid), tranexamic acid (topical or oral), azelaic acid, kojic acid, niacinamide. Long-term, low-grade lightening with minimal inflammation.
• Oral tranexamic acid — in selected patients (no thromboembolic risk factors), 250–500 mg daily can produce significant improvement.
• Low-fluence Q-switched lasers (Spectra peel) — produce gradual lightening with minimal inflammation. Multiple sessions.
• Chemical peels — conservative (mandelic acid, salicylic acid, gentle TCA at low concentrations) can be useful adjuncts.
• PicoSure / picosecond lasers — in selected cases.

Note that even these “safer” treatments can occasionally trigger flares; melasma always needs to be approached with the assumption that less aggressive is better.

Post-inflammatory hyperpigmentation (PIH) vs melasma

PIH is pigment that appears after any inflammation in the skin — an acne lesion, an injury, an aggressive treatment. It usually fades over months to years on its own. Microneedling can both cause PIH (in susceptible skin) and treat it (in other contexts).

For PIH from old acne or injury: shallow microneedling combined with topical lighteners is reasonable in Fitzpatrick I–III, used cautiously in IV–VI. For PIH from another aesthetic procedure that went poorly, the right move is often time + topicals rather than another aesthetic intervention.

Further reading

FAQ